abrdn plc elevated its place in shares of Veeva Methods Inc. (NYSE:VEEV – Free Report) by 86.1% through the third quarter, based on the corporate in its most up-to-date 13F submitting with the Securities and Change Fee. The institutional investor owned 30,060 shares of the know-how firm’s inventory after buying an extra 13,910 shares through the interval. abrdn plc’s holdings in Veeva Methods had been value $6,309,000 on the finish of the newest quarter.
A number of different hedge funds have additionally not too long ago purchased and offered shares of VEEV. Advisors Asset Administration Inc. acquired a brand new stake in Veeva Methods within the 1st quarter valued at about $28,000. Mowery & Schoenfeld Wealth Administration LLC acquired a brand new stake in Veeva Methods within the third quarter valued at about $26,000. Larson Monetary Group LLC raised its place in Veeva Methods by 1,153.8% within the 1st quarter. Larson Monetary Group LLC now owns 163 shares of the know-how firm’s inventory valued at $38,000 after buying an extra 150 shares within the final quarter. Blue Belief Inc. raised its place in Veeva Methods by 3,460.0% within the 2nd quarter. Blue Belief Inc. now owns 178 shares of the know-how firm’s inventory valued at $33,000 after buying an extra 173 shares within the final quarter. Lastly, DT Funding Companions LLC acquired a brand new stake in Veeva Methods within the 2nd quarter valued at about $35,000. Institutional buyers and hedge funds personal 88.20% of the corporate’s inventory.
Veeva Methods Buying and selling Up 1.9 %
Veeva Methods inventory opened at $212.78 on Friday. Veeva Methods Inc. has a twelve month low of $162.72 and a twelve month excessive of $236.90. The inventory has a 50 day transferring common of $212.62 and a two-hundred day transferring common of $199.03. The inventory has a market capitalization of $34.46 billion, a price-to-earnings ratio of 56.74, a PEG ratio of two.03 and a beta of 0.81.
Veeva Methods (NYSE:VEEV – Get Free Report) final posted its quarterly earnings information on Wednesday, August twenty eighth. The know-how firm reported $1.07 earnings per share for the quarter, topping analysts’ consensus estimates of $1.04 by $0.03. Veeva Methods had a return on fairness of 13.30% and a internet margin of 23.91%. The corporate had income of $676.18 million through the quarter, in comparison with analysts’ expectations of $667.21 million. Equities analysts predict that Veeva Methods Inc. will submit 4.21 earnings per share for the present 12 months.
Analyst Upgrades and Downgrades
Plenty of equities analysis analysts have issued stories on the corporate. Raymond James elevated their worth goal on Veeva Methods from $230.00 to $235.00 and gave the corporate an “outperform” ranking in a analysis report on Thursday, August twenty ninth. TD Cowen elevated their worth goal on Veeva Methods from $180.00 to $192.00 and gave the corporate a “maintain” ranking in a analysis report on Thursday, August twenty ninth. BNP Paribas initiated protection on Veeva Methods in a report on Tuesday, October eighth. They issued an “outperform” ranking and a $286.00 worth goal on the inventory. UBS Group elevated their worth goal on Veeva Methods from $185.00 to $215.00 and gave the corporate a “impartial” ranking in a report on Monday, August twenty sixth. Lastly, Citigroup elevated their worth goal on Veeva Methods from $256.00 to $273.00 and gave the corporate a “purchase” ranking in a report on Tuesday, August twenty seventh. One analyst has rated the inventory with a promote ranking, eight have assigned a maintain ranking and fifteen have issued a purchase ranking to the inventory. In keeping with information from MarketBeat, Veeva Methods has a consensus ranking of “Reasonable Purchase” and a consensus worth goal of $232.87.
Learn Our Newest Inventory Evaluation on Veeva Methods
Insiders Place Their Bets
In different information, SVP Jonathan Faddis offered 2,353 shares of the agency’s inventory in a transaction that occurred on Wednesday, August twenty first. The inventory was offered at a mean worth of $200.00, for a complete worth of $470,600.00. Following the completion of the sale, the senior vice chairman now immediately owns 9,035 shares of the corporate’s inventory, valued at $1,807,000. This commerce represents a 0.00 % lower of their place. The transaction was disclosed in a submitting with the Securities & Change Fee, which is out there by means of this hyperlink. 10.50% of the inventory is owned by insiders.
Veeva Methods Firm Profile
Veeva Methods Inc offers cloud-based software program for the life sciences business. It affords Veeva Industrial Cloud, a set of software program and analytics options, corresponding to Veeva buyer relationship administration (CRM) that allow customer-facing staff at pharmaceutical and biotechnology firms; Veeva Vault PromoMats, an end-to-end content material and digital asset administration resolution; Veeva Vault Medical that gives supply of medical content material throughout a number of channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical manufacturers; Veeva OpenData, a buyer reference information resolution; Veeva Hyperlink, a knowledge utility that enables hyperlink to generate real-time intelligence; and Veeva Compass contains de-identified and longitudinal affected person information for the USA.
See Additionally
Wish to see what different hedge funds are holding VEEV? Go to HoldingsChannel.com to get the most recent 13F filings and insider trades for Veeva Methods Inc. (NYSE:VEEV – Free Report).
Obtain Information & Rankings for Veeva Methods Each day – Enter your e-mail tackle beneath to obtain a concise every day abstract of the most recent information and analysts’ scores for Veeva Methods and associated firms with MarketBeat.com’s FREE every day e-mail publication.
